SCHEMBL2615249

SCHEMBL2615249

Cc1ccc2c(c1)C(=O)Cc1ccccc1N2C(N)=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.72
KMT2A Q03164 3/20 0.72
KDM4E B2RXH2 2/20 0.72
ALDH1A1 P00352 2/20 0.72
CYP3A4 P08684 1/20 0.72
MAPT P10636 1/20 0.72
PABPC1 P11940 1/20 0.72
BLM P54132 1/20 0.72
PDE5A O76074 2/20 0.46
NOTUM Q6P988 1/20 0.44
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
ATM Q13315 1/20 0.43
ACHE P22303 2/20 0.40
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
SCN4A P35499 1/20 0.39
SCN5A Q14524 1/20 0.39
SCN9A Q15858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19512822 0.90 KDM4E (0.72) MEN1KMT2AKDM4EALDH1A1CYP3A4
Oxcarbazepine SCHEMBL29433241 0.84 KDM4E (1.00) MEN1KMT2AKDM4EALDH1A1CYP3A4
Oxcarbazepine SCHEMBL29359799 0.84 KDM4E (1.00) MEN1KMT2AKDM4EALDH1A1CYP3A4
Oxcarbazepine SCHEMBL4655725 0.84 KDM4E (1.00) MEN1KMT2AKDM4EALDH1A1CYP3A4
Oxcarbazepine SCHEMBL35129 0.84 KDM4E (1.00) MEN1KMT2AKDM4EALDH1A1CYP3A4
SCHEMBL2615541 0.84 MEN1 (0.72) MEN1KMT2AKDM4EALDH1A1CYP3A4
Oxcarbazepine SCHEMBL17372732 0.83 KDM4E (0.97) MEN1KMT2AKDM4EALDH1A1CYP3A4
Oxcarbazepine SCHEMBL27944289 0.83 KDM4E (0.97) MEN1KMT2AKDM4EALDH1A1CYP3A4
Oxcarbazepine SCHEMBL29123953 0.82 ALDH1A1 (0.89) MEN1KMT2AKDM4EALDH1A1CYP3A4
Oxcarbazepine SCHEMBL2885435 0.80 KDM4E (0.89) MEN1KMT2AKDM4EALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF FLI1, CDC73, FOS MEN1 81/4885KMT2A 1417/4885KDM4E 2391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.